Literature DB >> 1287123

In vitro inhibition of tumor B cell growth by IgG-BF-producing Fc gamma RII+ T cell hybridoma and by immunoglobulin G-binding factors.

C Mathiot1, S Amigorena, J Moncuit, C Sautès, W H Fridman, J L Teillaud.   

Abstract

The growth-modulating effect on mouse hybridoma B cells of IgG-BF-producing Fc gamma RII+ mouse T cell hybridomas and of the IgG-BF isolated from the culture supernatants of these cells has been examined. Cocultures of IgG-secreting hybridoma B cells with IgG-BF-producing T hybridomas or with partially purified IgG-BF demonstrated a reproducible inhibition of the tumor B cell growth. The inhibition was due to a cytostatic and not to a cytotoxic effect. Hybridoma B cells cultured in liquid medium in the presence of soluble IgG-BF, or cocultured in semisolid agarose assays with IgG-BF-producing hybridoma T cells did not undergo immediate cytolysis but were prevented from proliferating. Thus, our data indicate that IgG-BF-producing Fc gamma RII+ T cells interfere with the proliferation of transformed B cells, possibly through soluble IgG-BF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1287123     DOI: 10.1007/bf02919135

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  46 in total

1.  Immunoglobulin G-binding factors (IgG-BF) inhibit IgG secretion by, as well as proliferation of, hybridoma B cells.

Authors:  J L Teillaud; S Amigorena; J Moncuit; C Sautès; W H Fridman
Journal:  Immunol Lett       Date:  1987-11       Impact factor: 3.685

2.  Regulation of hybridoma B-cell proliferation by immunoglobulin-binding factor.

Authors:  J L Teillaud; C Mathiot; S Amigorena; S Brunati; J Moncuit; W H Fridman
Journal:  Cancer Detect Prev       Date:  1988

3.  IgD-binding factors from mouse T lymphocytes.

Authors:  M Adachi; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

Review 4.  Characterization and function of T cell Fc gamma receptor.

Authors:  W H Fridman; C Rabourdin-Combe; C Neauport-Sautes; R H Gisler
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

5.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

Authors:  C M Snapper; W E Paul
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

6.  Presence of an antigenic determinant common to rat IgE-potentiating factor, IgE-suppressive factor, and Fc epsilon receptors on T and B lymphocytes.

Authors:  T F Huff; J Yodoi; T Uede; K Ishizaka
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

7.  Expansion of Fc receptor-bearing T lymphocytes in patients with immunoglobulin G and immunoglobulin A myeloma.

Authors:  R G Hoover; S Hickman; H M Gebel; N Rebbe; R G Lynch
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

8.  Immunoglobulin secretion by mouse X human hybridomas: an approach for the production of anti-idiotype reagents useful in monitoring patients with B cell lymphoma.

Authors:  S Brown; J Dilley; R Levy
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

9.  T cell hybridomas coexpressing Fc receptors (FcR) for different isotypes. II. IgA-induced formation of suppressive IgA binding factor(s) by a murine T hybridoma bearing Fc gamma R and Fc alpha R.

Authors:  J Yodoi; M Adachi; K Teshigawara; M Miyamainaba; T Masuda; W H Fridman
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

10.  T lymphocyte-mediated suppression of myeloma function in vitro. II. Evidence for regulation of hapten-binding myelomas by syngeneic hapten-specific cytolytic T lymphocytes.

Authors:  A K Abbas; S E Ratnofsky; S J Burakoff
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.